TranS1 was granted patents addressing presacral interbody fusion technologies, including two new expandable cages designed to create lordosis at L5-S1 and a new sacroiliac fusion technique.
In all, the company has >100 issued patents and has filed >50 applications in the last three years.
The TranS1 portfolio comprises minimally invasive approaches with the Pylon™ system for posterolateral decortication and bone graft placement, KeyLIF™ MIS Oblique Lateral Interbody Fusion system and AxiaLIF® presacral interbody fusion.
TranS1 was granted patents addressing presacral interbody fusion technologies, including two new expandable cages designed to create lordosis at L5-S1 and a new sacroiliac fusion technique.
In all, the company has >100 issued patents and has filed >50 applications in the last three years.
The TranS1 portfolio comprises minimally...
TranS1 was granted patents addressing presacral interbody fusion technologies, including two new expandable cages designed to create lordosis at L5-S1 and a new sacroiliac fusion technique.
In all, the company has >100 issued patents and has filed >50 applications in the last three years.
The TranS1 portfolio comprises minimally invasive approaches with the Pylon™ system for posterolateral decortication and bone graft placement, KeyLIF™ MIS Oblique Lateral Interbody Fusion system and AxiaLIF® presacral interbody fusion.
Copy to clipboard 
